NeuroMetrix NUROW 深 沪
等待开盘 05-21 09:30:00 美东时间
0.142
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.142
- 总市值 144.65万
- 52周最高 1.48
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.012
- 委 比 0.00%
- 总股本 1018.63万
- 历史最高 5.60
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.012
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多electroCore Announces First Quarter 2026 Financial Results
ElectroCore, Inc. reported Q1 2026 net sales of $9.6 million, a 43% year-over-year increase, driven by growth in VA prescription sales and Truvaga direct-to-consumer sales. The company also saw a 24% improvement in adjusted EBITDA loss to $2.3 million. Key highlights include VA prescription gammaCore revenue up 26%, Quell product line sales surpassing $1.0 million quarterly revenue, and Truvaga revenue growing 38% with improved marketing efficien...
05-06 20:05
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
- ElectroCore announces 2025 full-year net sales of $32.0 million, up 27% from $25.2 million in 2024, driven by 25% growth in US prescription business and 97% increase in general wellness sales. - CEO Dan Goldberger to retire effective April 1, 2026; Joshua Lev named interim President and CFO; Michael Fox joins as COO. - 2026 revenue guidance targets 30% annual growth. - Conference call and webcast scheduled for March 19, 2026, at 4:30 PM EDT.
03-19 20:05
Medical tech firm ElectroCore Q2 revenue beats expectations
Overview ElectroCore Inc Q2 revenue rises 20% yr/yr, beating analyst expectations Co's GAAP net loss widens to $3.7 mln due to higher expenses Completed acquisition of NeuroMetrix, raised $7.2 mln thr...
2025-08-07 04:31
electroCore Inc. Reports 20% Increase in Q2 2025 Net Sales to $7.4 Million; GAAP Net Loss Widens to $3.7 Million, EPS at $0.44 Loss
electroCore, Inc. has reported its financial results for the second quarter of 2025, highlighting a record revenue of $7.4 million, which marks a 20% increase over the same quarter in 2024. Year-to-da...
2025-08-07 04:17
NeuroMetrix Inc. Completes Merger, Converts Common Stock into Cash and Contingent Value Rights
NeuroMetrix Inc. announced the completion of its merger, effective May 1, 2025. As part of the transaction, each share of NeuroMetrix's common stock was cancelled and converted into the right to recei...
2025-05-02 20:35
NeuroMetrix Inc. Files Amendment to 10-K Annual Report
NeuroMetrix Inc. has filed an amendment to the 10-K annual report for the fiscal year ended December 31, 2024. The full filing can be accessed through the link below. Disclaimer: This news brief was c...
2025-05-01 05:02
NeuroMetrix Inc. Announces Special Meeting of Stockholders to Consider Merger Proposal
NeuroMetrix Inc. has announced that it will hold a special meeting of stockholders via the Internet. The date of the meeting has not been confirmed yet. During the meeting, shareholders will be asked ...
2025-02-01 01:00
Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law Firm
NEW YORK, Dec. 18, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may see...
2024-12-18 22:03
Electrocore to Acquire NeuroMetrix Enhancing Bioelectronic Offerings
Electrocore ( ($ECOR) ) has shared an update. On December 17, 2024, electroCore...
2024-12-18 06:49
NeuroMetrix Merges with electroCore, Expands Quell Access
An update from Neurometrix ( ($NURO) ) is now available. NeuroMetrix, Inc. has ...
2024-12-18 06:49
